Curated News: Medical Meetings

Filters close
Released: 6-Apr-2022 7:00 AM EDT
Alcohol Consumption Has No Additional Preventative Heart Benefits in Patients on Cholesterol Lowering Medication
Intermountain Healthcare

A new study by researchers at Intermountain Healthcare in Salt Lake City finds that alcohol consumption does not provide additional heart benefits in cardiology patients already being treated with statins – the most commonly used drugs to lower cholesterol.

25-Mar-2022 9:00 AM EDT
Study Reveals How Deadly Tick Disease Spreads
Federation of American Societies for Experimental Biology (FASEB)

Findings from a new study are providing important insights into the spread of Rocky Mountain spotted fever, which is transmitted from dogs to people through ticks. The new data are being used to create models that could help predict, and possibly prevent, future outbreaks.

25-Mar-2022 9:00 AM EDT
Researchers Uncover How Sugar Substitutes Disrupt Liver Detoxification
Federation of American Societies for Experimental Biology (FASEB)

Results from a new study suggest that two sugar substitutes disrupt the function of a protein that plays a vital role in liver detoxification and the metabolism of certain drugs. These sugar substitutes, also known as non-nutritive sweeteners, provide a sweet taste with few or no calories.

25-Mar-2022 9:00 AM EDT
Vitamin K Shows Evidence of Brain Benefits in Rats
Federation of American Societies for Experimental Biology (FASEB)

In a new study conducted in rats, scientists report evidence that vitamin K could help protect against aging-related cognitive declines associated with Alzheimer’s disease and other forms of dementia.

5-Apr-2022 10:15 AM EDT
Diagnosing Sports-Related Concussions May Be Harder than Thought
Rutgers University-New Brunswick

The tool being used to diagnose concussions might be overestimating the condition and wrongly identifying symptoms like fatigue and neck pain caused from intense exercise and not a brain injury, according to Rutgers researchers. This new research raises new questions about the Sport Concussion Assessment Tool (SCAT), a questionnaire widely used along with other methods to diagnose concussions sustained during sports. Findings were presented at the American Physiological Society annual meeting April 5.

25-Mar-2022 9:00 AM EDT
Diagnosing Sports-Related Concussions May Be Harder than Previously Thought
Federation of American Societies for Experimental Biology (FASEB)

In a new study, many athletes reported symptoms that are often used to diagnose concussions even though they did not suffer a head injury. The findings suggest that some symptoms, such as fatigue and neck pain, could be attributed to intense exercise rather than a brain injury.

25-Mar-2022 9:00 AM EDT
Gut Bacteria May Contribute to Blood Pressure Medicine Resistance
Federation of American Societies for Experimental Biology (FASEB)

Almost half of the U.S. adult population has high blood pressure — or hypertension — and about 20% of these patients have treatment-resistant hypertension. The reason why some people are resistant to treatment has been a mystery, but new study results show that a certain gut bacterium may be an important factor.

25-Mar-2022 9:00 AM EDT
Autism-Associated Brain Differences Can Be Observed in the Womb
Federation of American Societies for Experimental Biology (FASEB)

A new study using prenatal brain scans revealed significant differences in brain structures at around 25 weeks’ gestation between children who were later diagnosed with ASD and those who were not. The study adds to mounting evidence that autism begins in early development and suggests possible opportunities to identify the disorder at an earlier age.

25-Mar-2022 9:00 AM EDT
Proteins in Saliva Could Aid in COVID-19 Detection and Predict Severe Illness
Federation of American Societies for Experimental Biology (FASEB)

Researchers have identified a family of proteins that is significantly elevated in the saliva of patients hospitalized with COVID-19. The proteins, known as ephrin ligands, could potentially serve as a biomarker to help doctors identify patients who are at risk for serious illness.

25-Mar-2022 9:00 AM EDT
Scientists Identify Cancer Biomarkers in Breast Milk
Federation of American Societies for Experimental Biology (FASEB)

A simple blood test for women of all ages and risk levels could one day be possible thanks to a new set of protein biomarkers that researchers identified using breast milk.

25-Mar-2022 9:00 AM EDT
Vitamin C Could Help Reduce Toxic Side Effects of Common Cancer Treatment
Federation of American Societies for Experimental Biology (FASEB)

A study conducted in rats suggests that taking vitamin C may help to counteract the muscle atrophy that is a common side effect of the chemotherapy drug doxorubicin. Although clinical studies would be needed to determine the safety and effectiveness of taking vitamin C during doxorubicin treatment, the findings suggest vitamin C may represent a promising opportunity to reduce some of the drug’s most debilitating side effects.

25-Mar-2022 9:00 AM EDT
Scientists Uncover Why Long COVID Can Cause Pain
Federation of American Societies for Experimental Biology (FASEB)

A new animal study has provided important insights into how COVID-19 SARS-CoV-2 — the virus responsible for COVID-19 — can lead to long-term pain. The new findings also point to a potential therapy for COVID-related pain.

25-Mar-2022 9:00 AM EDT
Animal Study Shows Safety of Using CBD and THC with Opioids
Federation of American Societies for Experimental Biology (FASEB)

Findings from a new animal study suggest that cannabidiol (CBD) and tetrahydrocannabinol (THC) might be safe for use with opioid pain relievers. Although more studies are needed, the results suggest that these compounds might be a low-risk way to reduce the dose of opioids needed to relieve pain.

Newswise: ACC22: Interim Findings Show Promise in Decreasing Shortness of Breath From Hypertrophic Cardiomyopathy
Released: 4-Apr-2022 1:05 AM EDT
ACC22: Interim Findings Show Promise in Decreasing Shortness of Breath From Hypertrophic Cardiomyopathy
Cedars-Sinai

A new drug shows promise in providing relief to hypertrophic cardiomyopathy patients experiencing shortness of breath, according to late-breaking research presented today at the American College of Cardiology (ACC) Scientific Session in Washington, D.C.

25-Mar-2022 9:00 AM EDT
Exercise Could Help Reduce Severity of Serious Cancer Complication
Federation of American Societies for Experimental Biology (FASEB)

A new study has identified yet another benefit of keeping up your exercise routine. In experiments performed with mice, researchers found that exercising prior to developing cancer was associated with slower tumor growth and helped reduce the effects of a cancer complication known as wasting syndrome, or cachexia.

25-Mar-2022 9:00 AM EDT
Cardamonin Shows Promise for Treating Aggressive Breast Cancer
Federation of American Societies for Experimental Biology (FASEB)

Cardamonin — a natural compound found in the spice cardamom and other plants — could have therapeutic potential for triple-negative breast cancer, according to a new study using human cancer cells. The findings also show that the compound targets a gene that helps cancer cells elude the immune system.

3-Apr-2022 12:15 PM EDT
Investigational Anti-Clotting Drug Reduces Bleeding Risk Among AF Patients
Duke Health

A new type of anti-clotting drug caused fewer bleeding incidents among patients with atrial fibrillation than the commonly prescribed apixaban, according to results from a head-to-head comparison of the two.

3-Apr-2022 12:15 PM EDT
Few Patients Have Infected Heart Devices Removed Despite Lifesaving Benefits
Duke Health

Medicare patients whose implantable heart devices became infected were less likely to die from the complication if they had the hardware removed compared to patients who only received antibiotics, according to the largest study on the topic, led by the Duke Clinical Research Institute.

Newswise: International Precision Neuroscience Conference to Explore Brain Cancer, Mental Health, Neurodegeneration
Released: 3-Apr-2022 12:05 PM EDT
International Precision Neuroscience Conference to Explore Brain Cancer, Mental Health, Neurodegeneration
Virginia Tech

The Precision Neuroscience Conference builds on a collaboration between Nordic and Virginia universities. It will be held at Virginia Tech and feature scientists presenting work involving forward-looking applications of precision medicine.

25-Mar-2022 9:00 AM EDT
Mineral Supplement Could Stop Fatty Liver Disease Progression
Federation of American Societies for Experimental Biology (FASEB)

Results from a preclinical study add new evidence that a multi-mineral dietary supplement known as Aquamin could be a simple and effective way to reduce the long-term health consequences of non-alcoholic fatty liver disease. Aquamin, which is derived from calcified red marine algae, is rich in calcium, magnesium and 72 other minerals and trace elements.

2-Apr-2022 8:00 AM EDT
Cleveland Clinic-Led Trial Finds That Experimental ‘Gene Silencing’ Therapy Reduces Lipoprotein(a), an Important Risk Factor of Heart Disease, By Up To 98%
Cleveland Clinic

Findings from a new Cleveland Clinic-led phase 1 trial show that an experimental “gene silencing” therapy reduced blood levels of lipoprotein(a), a key driver of heart disease risk, by up to 98%. Findings from the “APOLLO Trial: Magnitude and Duration of Effects of a Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial” were presented today during a late-breaking science session at American College of Cardiology’s 71st Annual Scientific Session and simultaneously published online in the Journal of the American Medical Association.

1-Apr-2022 12:10 PM EDT
Cleveland Clinic-Led Trial Shows Drug Effective in Nearly 80% of Patients with Hypertrophic Cardiomyopathy
Cleveland Clinic

Findings from a Cleveland Clinic-led clinical trial showed that the use of an experimental drug in severely symptomatic, hypertrophic cardiomyopathy patients significantly reduced the need for invasive procedures.

Newswise: Antioxidant, Inflammation Levels May Reveal New Diagnostic Tool for Breast Cancer
25-Mar-2022 8:00 AM EDT
Antioxidant, Inflammation Levels May Reveal New Diagnostic Tool for Breast Cancer
American Physiological Society (APS)

A new study that analyzes levels of antioxidants and stress markers in the blood could lead to a new diagnostic tool for breast cancer. The research will be presented this week in Philadelphia at the American Physiological Society’s (APS) annual meeting at Experimental Biology 2022.

Newswise: High Caffeine Consumption Disrupts Heart Rhythms in Middle-aged Rats
31-Mar-2022 8:30 AM EDT
High Caffeine Consumption Disrupts Heart Rhythms in Middle-aged Rats
American Physiological Society (APS)

New research finds that excess caffeine is more likely to cause irregular heart rhythms in middle aged rats than in young adult rats. The study will be presented this week at the American Physiological Society annual meeting at Experimental Biology 2022 in Philadelphia.

Newswise: Five Minutes of Daily Breath Training Improves Exercise Tolerance in Middle-aged and Older Adults
25-Mar-2022 8:00 AM EDT
Five Minutes of Daily Breath Training Improves Exercise Tolerance in Middle-aged and Older Adults
American Physiological Society (APS)

New research finds potential for high-resistance inspiratory muscle strength training to help sedentary middle-aged and older adults transition to a healthier lifestyle. The study will be presented this week at the American Physiological Society annual meeting at Experimental Biology 2022.

Newswise:Video Embedded exercise-improves-health-markers-in-young-female-survivors-of-childhood-trauma
VIDEO
25-Mar-2022 8:00 AM EDT
Exercise Improves Health Markers in Young Female Survivors of Childhood Trauma
American Physiological Society (APS)

New research shows a progressive exercise training program mitigates some physiological and psychological effects of adverse childhood experiences in otherwise healthy young women. The study will be presented at the American Physiological Society annual meeting at Experimental Biology 2022.

Newswise: Smokers Less Likely to Survive a Heart Attack
25-Mar-2022 8:05 AM EDT
Smokers Less Likely to Survive a Heart Attack
American Physiological Society (APS)

Smokers have a lower chance of surviving a heart attack than non-smokers, according to new data compiled by researchers at Jordan University of Science and Technology in Irbid.

Newswise: Hope Builds for New Therapeutics to Reverse or Prevent Alzheimer’s
25-Mar-2022 7:55 AM EDT
Hope Builds for New Therapeutics to Reverse or Prevent Alzheimer’s
American Physiological Society (APS)

A new study from the University of Mississippi Medical Center in Jackson finds that (Aβ) accumulation in AD is associated with reduced blood flow to the brain, known as cerebral hypoperfusion.

Newswise: Blueberry Extract May Aid Wound Healing
25-Mar-2022 8:00 AM EDT
Blueberry Extract May Aid Wound Healing
American Physiological Society (APS)

Treating wounds with an extract taken from wild blueberries may improve healing, according to a new study. The research will be presented this week in Philadelphia at the American Physiological Society’s (APS) annual meeting at Experimental Biology 2022.

Newswise:Video Embedded a-prune-or-six-a-day-may-keep-inflammation-at-bay
VIDEO
25-Mar-2022 8:00 AM EDT
A Prune—Or Six—a Day May Keep Inflammation at Bay
American Physiological Society (APS)

A study in postmenopausal people suggests eating nutrient-rich prunes every day may be beneficial to bone health, reducing inflammatory factors that contribute to osteoporosis. The research will be presented this week in Philadelphia at the American Physiological Society’s (APS) annual meeting at Experimental Biology 2022.

Newswise: Virtual Population Model Predicts and Stops Kidney Damage in Black Americans
25-Mar-2022 8:05 AM EDT
Virtual Population Model Predicts and Stops Kidney Damage in Black Americans
American Physiological Society (APS)

Researchers have successfully used a virtual population to replicate a clinical trial that examined kidney damage in Black Americans, according to a new study at the University of Mississippi Medical Center in Jackson.

25-Mar-2022 9:00 AM EDT
Yo-Yo Dieting and Food Insecurity May Raise Heart Disease Risk
Federation of American Societies for Experimental Biology (FASEB)

Fluctuations in body weight resulting from drastically cutting and increasing calories may lead to physiological changes that raise the risk of heart disease or diabetes later in life, according to a study being presented at the American Physiological Society annual meeting during the Experimental Biology (EB) 2022 meeting, held in Philadelphia April 2–5.

25-Mar-2022 9:00 AM EDT
Plant Compound Shows Promise for Alleviating Food Allergies
Federation of American Societies for Experimental Biology (FASEB)

Researchers combined advanced computational methods with experimental studies to gain new insight, at the cell level, into how the plant compound formononetin might be used to treat food allergies. With nearly 10% of the world population affected by food allergies — which are sometimes life-threatening — new treatments are critically needed.

25-Mar-2022 9:00 AM EDT
COVID-19 Vaccine-Associated Menstrual Symptoms Reported in Non-Menstruating People
Federation of American Societies for Experimental Biology (FASEB)

Many people who do not usually menstruate reported experiencing breakthrough bleeding or other period symptoms after receiving a COVID-19 vaccine, according to new findings from an online survey by researchers at Washington University in St. Louis.

25-Mar-2022 9:00 AM EDT
Omega-3s Could Boost Immunotherapy’s Cancer-Fighting Power
Federation of American Societies for Experimental Biology (FASEB)

Findings from a new study performed in mice suggest that omega-3 fatty acids could help immunotherapy and other treatments do a better job at fighting cancer. Immunotherapies, which stimulate the body’s own immune system to attack cancer, have revolutionized cancer treatment, but they don’t work for every patient.

25-Mar-2022 9:00 AM EDT
Researchers Harness Probiotics to Deliver Parkinson’s Disease Treatment
Federation of American Societies for Experimental Biology (FASEB)

Researchers have engineered probiotic bacteria that can synthesize the dopamine precursor L-DOPA, a powerful mainstay treatment for Parkinson’s disease. Preclinical tests show that the new treatment approach is not only safe and well-tolerated but also eliminates side effects that eventually develop when L-DOPA is taken orally.

28-Mar-2022 3:05 PM EDT
Preliminary Study: Drug May Be Safe in Those with Mild Cognitive Impairment, Mild Dementia
American Academy of Neurology (AAN)

A small, preliminary study of an investigational new drug being studied for mild cognitive impairment and mild dementia associated with Alzheimer’s disease suggests it is safe and may be associated with improvements in executive function, thinking and memory skills. The study is released today, March 31, 2022, and will be presented at the American Academy of Neurology’s 74th Annual Meeting being held in person in Seattle, April 2 to 7, 2022 and virtually, April 24 to 26, 2022. The drug, called SAGE-718, is also in clinical trials for the treatment of cognitive impairment associated with Parkinson’s disease and Huntington’s disease.

Newswise: AACR Tipsheet: Cancer Experts to Discuss Advances in Treatment
Released: 31-Mar-2022 11:05 AM EDT
AACR Tipsheet: Cancer Experts to Discuss Advances in Treatment
Cedars-Sinai

Cedars-Sinai Cancer experts will present their latest advances in treatments and research at the American Association for Clinical Research (AACR) Annual Meeting 2022 in New Orleans, April 8-13. They will share their innovations to improve the quality of patient care.

Released: 31-Mar-2022 8:05 AM EDT
NCCN Annual Conference Focuses on Cancer Patient Journey; with Cutting-Edge Research and Latest Evidence-Based Care Recommendations
National Comprehensive Cancer Network® (NCCN®)

Three-day #NCCN2022 virtual oncology conference from National Comprehensive Cancer Network includes more than 30 educational sessions on the latest in cancer care plus more than 200 electronic posters presenting new research in oncology.

Newswise: Cedars-Sinai Neurologists Participate in American Academy of Neurology Conference
Released: 30-Mar-2022 5:05 PM EDT
Cedars-Sinai Neurologists Participate in American Academy of Neurology Conference
Cedars-Sinai

Cedars-Sinai neurology experts are available to discuss the latest advances in research and clinical care for patients with disorders of the nervous system ahead of the 74th annual meeting of the American Academy of Neurology (AAN), happening April 2-7.

28-Mar-2022 3:05 PM EDT
Experimental Drug Linked to Reduced Tics in Children, Teens with Tourette Syndrome
American Academy of Neurology (AAN)

According to a new preliminary study, children and teens with Tourette syndrome who are treated with an experimental drug called ecopipam may have improved scores on tests of tic severity three months later. The research being released today, March 30, 2022, will be presented at the American Academy of Neurology’s 74th Annual Meeting being held in person in Seattle, April 2 to 7, 2022 and virtually, April 24 to 26, 2022. Tourette syndrome is a neurological disorder characterized by motor and verbal tics, which are repetitive movements and vocalizations prompted by an irresistible urge to produce them.

28-Mar-2022 3:05 PM EDT
Study: Brain Implant Safe, May Help Those with Paralysis Use Computer for Daily Tasks
American Academy of Neurology (AAN)

An investigational device called a brain-computer interface has been found safe in a small study of people with paralysis from ALS, and has allowed participants to use a computer to communicate by text and do daily tasks such as online shopping and banking, according to a preliminary study released today, March 29, 2022, that will be presented at the American Academy of Neurology’s 74th Annual Meeting being held in person in Seattle, April 2 to 7, 2022 and virtually, April 24 to 26, 2022.

Released: 29-Mar-2022 8:05 AM EDT
Saline Treatment Can Reverse Nerve Block Lung Complication, But Needs 30 Minutes to Take Effect – Too Long for Some Patients
American Society of Regional Anesthesia and Pain Medicine (ASRA)

Researchers at Stanford University are working to identify how to reverse a rare but potentially fatal side effect of a commonly provided nerve block for patients receiving shoulder surgery. Given how common the surgery is, this work has vast implications.

25-Mar-2022 5:30 PM EDT
New HSS Study Finds Safe and Effective Outcomes After Innovative ACL Reconstruction Technique in Children and Adolescents at High Risk for Re-Tears
Hospital for Special Surgery

A new study by researchers at Hospital for Special Surgery (HSS) in New York City presented today at the American Academy of Orthopaedic Surgeons (AAOS) 2022 Annual Meeting found that a novel surgical technique performed during anterior cruciate ligament (ACL) reconstruction in certain younger patients garnered positive results two years post-surgery.

Released: 25-Mar-2022 9:30 AM EDT
Experimental Biology 2022 Press Materials Available Now
Federation of American Societies for Experimental Biology (FASEB)

Embargoed press materials are now available for the Experimental Biology (EB) 2022 meeting, featuring cutting-edge research from across the life sciences. EB 2022, to be held April 2–5 in Philadelphia, is the annual meeting of five scientific societies bringing together thousands of scientists and 25 guest societies in one interdisciplinary community.

Released: 25-Mar-2022 9:00 AM EDT
Announcing Virtual Press Conference for Experimental Biology 2022 Meeting
Federation of American Societies for Experimental Biology (FASEB)

Reporters are invited to join a live discussion of research announcements at the forefront of the life sciences during a virtual press conference for the Experimental Biology (EB) 2022 meeting. The press conference will be held online from 11–11:45 a.m. Eastern on Friday, April 1, 2022 (RSVP by Thursday, March 31).

22-Mar-2022 12:50 PM EDT
American Academy of Dermatology Installs New Officers, Board Members
American Academy of Dermatology

Immediately following the American Academy of Dermatology’s Annual Meeting, three new officers and four new board members will be installed to help lead the world’s largest dermatologic society and represent more than 20,500 physicians who specialize in the diagnosis and medical, surgical, and cosmetic treatment of skin, hair, and nail conditions.

22-Mar-2022 12:55 PM EDT
Mark D. Kaufmann, MD, FAAD, Assumes Presidency of the American Academy of Dermatology
American Academy of Dermatology

Annual Meeting, board-certified dermatologist Mark D. Kaufmann, MD, FAAD, will begin his one-year term as president of the AAD.

22-Mar-2022 1:10 PM EDT
What’s Causing Your Child’s Itchy Rash?
American Academy of Dermatology

Itchy rashes can be very irritating, especially when children get them, and you don’t know what is causing them.

22-Mar-2022 1:00 PM EDT
How Does Your Environment Affect Your Skin?
American Academy of Dermatology

A dermatologist addresses the skin problems caused by bugs, plants and water creatures.



close
3.45047